Influenza viruses have a huge impact on public health. Current influenza vaccines need to
be updated annually and protect poorly against antigenic drift variants or novel emerging …

Introduction: The public health burden of seasonal influenza is significant, and influenza
vaccination is the most effective preventive strategy. Nonetheless, the recommendation of …

Introduction Prior studies showed that live attenuated influenza vaccine (LAIV) is more
effective than inactivated influenza vaccine (IIV) in children aged 2–8 years, supporting the …

Vaccination is the most effective means of preventing influenza. However, the cost of
producing annual seasonal influenza vaccines puts them out of reach for most developing …

Drugs, medical treatment procedures, medical devices, surgical techniques and health
systems in the healthcare field are in the scope of Health Technology Assessment (HTA) …

Background: Limited data on the influenza burden in pediatric outpatients are available,
especially regarding direct comparison of the cocirculating (sub) types A (H1N1) pdm09, A …

Introduction Prior evidence found live attenuated influenza vaccine (LAIV) more effective
than inactivated influenza vaccine (IIV) in children aged 2–8 years, leading CDC in 2014 to …

The lack of population immunity to the periodically emerging pandemic influenza strains
makes influenza infection especially dangerous. The fragmented nature of the influenza …

Background We report a phase III/IV open-label study on the immunogenicity of a single
dose of a Live Attenuated Influenza Vaccine (LAIV)(Fluenz™) in children naïve to, or in …

Abstract Inactivated (whole-virion, split, subunit, and adjuvanted) vaccines and live
attenuated vaccine were tested in parallel to compare their immunogenicity and protective …